Effect of Prostatic Urethra and Seminal Vesicle Morphometry... | Clinical Trial | StuddyBuddy@endsection Effect of Prostatic Urethra and Seminal Vesicle Morphometry on Ejaculation
Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Not Yet Recruiting NCT07614854

Effect of Prostatic Urethra and Seminal Vesicle Morphometry on Ejaculation

Conditions: Premature Ejaculation, Ejaculation

Sex: Male
Ages: 18 Years – 55 Years
Healthy volunteers: Yes
Enrollment: 150
Sponsor: Başakşehir Çam & Sakura City Hospital

Location: Başakşehir Çam and Sakura City Hospital, Department of Urology Istanbul Istanbul

Summary

The goal of this observational study is to learn whether the size and shape of the prostatic urethra and seminal vesicles - measured on multiparametric prostate MRI (mpMRI) - are related to premature ejaculation (PE) severity in men aged 18-55. The main questions it aims to answer are: * Do men with premature ejaculation have different prostatic urethral length and angulation compared to men without PE? * Do men with premature ejaculation have different seminal vesicle dimensions compared to men without PE? * Do prostatic urethra and seminal vesicle measurements on mpMRI correlate with PE severity scores (PEDT) and ejaculation latency time (IELT)? Researchers will compare men with premature ejaculation to healthy men without ejaculatory complaints to see if specific anatomical features are associated with PE severity. Participants will: * Undergo a multiparametric prostate MRI that is already scheduled as part of their routine medical care * Complete validated questionnaires about ejaculation and sexual function (PEDT, PEP, IELT, IIEF-15) * Provide a blood sample for routine hormone level measurements

Eligibility Criteria

Inclusion Criteria: * \- Male aged 18 to 55 years * In a stable, heterosexual, monogamous relationship with the same female partner for at least 6 months * Normal erectile function defined as IIEF-15 erectile function domain score ≥26 * Scheduled for clinically indicated multiparametric prostate MRI due to elevated PSA or hematospermia * Not using any medication that may affect sexual function or psychological status (e.g., SSRIs, PDE5 inhibitors) Exclusion Criteria: * Any major psychiatric or somatic disorder * Hormonal disorders such as hypothyroidism or hyperthyroidism * Erectile dysfunction (IIEF-15 erectile function domain score \

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT07614854). StuddyBuddy aggregates publicly available trial information.